Seung-mi Kim
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Mutant PIK3CA as a negative predictive biomarker for treatment with a highly selective PIM1 inhibitor in human colon cancer.
Journal: Cancer biology & therapy
Published: August 25, 2023
miR-3188 Enhances Sensitivity of Breast Cancer Cells to Ionizing Radiation by Down-regulating Rictor.
Journal: Anticancer research
Published: September 16, 2021
Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations.
Journal: British journal of cancer
Published: March 13, 2018
Human breast cancer cells display different sensitivities to ABT-263 based on the level of survivin.
Human breast cancer cells display different sensitivities to ABT-263 based on the level of survivin.
Journal: Toxicology in vitro : an international journal published in association with BIBRA
Published: February 25, 2017
Combined treatment with vitamin C and sulindac synergistically induces p53- and ROS-dependent apoptosis in human colon cancer cells.
Journal: Toxicology letters
Published: March 14, 2016
L-Ascorbic acid can abrogate SVCT-2-dependent cetuximab resistance mediated by mutant KRAS in human colon cancer cells.
Journal: Free radical biology & medicine
Published: September 19, 2015
SH003 selectively induces p73‑dependent apoptosis in triple‑negative breast cancer cells.
Journal: Molecular medicine reports
Published: July 30, 2015
SAHA, an HDAC inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by modulating E-cadherin.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: July 04, 2015
Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinoma.
Journal: Clinical and molecular hepatology
Published: October 28, 2014
Targeting FGFR Pathway in Human Hepatocellular Carcinoma: Expressing pFGFR and pMET for Antitumor Activity.
Journal: Molecular cancer therapeutics
Published: September 11, 2014
TFAP2E methylation status and prognosis of patients with radically resected colorectal cancer.
Journal: Oncology
Published: February 15, 2014
The survivin suppressant YM155 potentiates chemosensitivity to gemcitabine in the human pancreatic cancer cell line MiaPaCa-2.
Journal: Anticancer research
Published: May 18, 2012
Last Updated: 09/26/2026